Prof. Dr. Aliye BAŞTUĞ

1. Epidemiological characteristics and risk factors associated with bacteremia caused by intrinsically colistin-resistant gram-negative microorganisms: a case–control study

Büyüktarakçı Karali C., BAŞTUĞ A., SERTÇELİK A., BODUR H.

BMC Infectious Diseases , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Evaluating the risk: Hepatitis B virus reactivation in ocrelizumab-treated patients with multiple sclerosis: A single-center experience and review of the literature

Ozbay B. O., Kulu U., BAŞTUĞ A., Koçak Y., İşbilen Y., Aksoy D.

Multiple Sclerosis and Related Disorders , cilt.113, 2026 (SCI-Expanded, Scopus)

3. Risk factors and vaccination gaps for herpes zoster in people living with HIV: A multicenter multivariable study

Akca V., Akbulut İ., YILMAZ G., KAYAASLAN B., ESER F., Baygüneş S. N., et al.

International Journal of STD and AIDS , cilt.37, 2026 (SCI-Expanded, Scopus)

4. Beyond viral suppression: determinants of health-related quality of life in a national HIV cohort in Turkiye

KARACAER Z., Bozdag M., ASAR E., BAŞTUĞ A., Ozturk B., ERTÜRK D., et al.

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV , 2026 (SSCI, Scopus)

5. Postexposure prophylaxis for HIV among healthcare workers in Türkiye: a descriptive, multicenter retrospective study

Akca V., Akbulut İ., YILMAZ G., Tahmaz A., Öztoprak Çuvalci N., Esen Yildiz İ., et al.

Turkish Journal of Medical Sciences , cilt.56, sa.2, ss.518-530, 2026 (SCI-Expanded, Scopus, TRDizin)

6. Long-term metabolic and safety profiles of tenofovir alafenamide and tenofovir disoproxil fumarate in ART-naive people living with HIV: a multicenter retrospective study using a mixed-effects model

Karabay O., Vatan A., Ucar A., Yilmaz I., Balta N. C., Kanturk A., et al.

BMC Pharmacology and Toxicology , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus)

7. Prevalence Rates and Outcomes of Hyponatremia in Patients with Crimean-Congo Hemorrhagic Fever

Ozbay B. O., BAŞTUĞ A., Hanoğlu Y.

Vector-Borne and Zoonotic Diseases , cilt.25, sa.5, ss.359-364, 2025 (SCI-Expanded, Scopus)

8. Serum Ferritin as a Predictor of Hospital Mortality in Critically Ill COVID-19 Patients

Soykan F., Bolukbasi D., Toy E., Selmi N. H., Yavuz A., Kosovali B. D., et al.

COVID , cilt.5, sa.4, 2025 (ESCI, Scopus)

9. Epidemiology of Kidney Disease in People Living with HIV in Türkiye; Comorbidities and Drug Toxicities are Emerging Problems

ESER F., KAYAASLAN B., Senturk G. C., SÖNMEZER M. Ç., BAŞTUĞ A., BİRENGEL M. S., et al.

Current HIV Research , cilt.23, sa.5, ss.339-349, 2025 (SCI-Expanded, Scopus)

10. Consensus paper on Candida auris by Türkiye EKMUD, ID-IRI, THSK of Ministry of Health of the Republic of Türkiye, KLIMUD, TMC, TARD, and TYBD

Ağalar C., ERDEM H., Çağ Y., Arda B., Balik R., BAŞTUĞ A., et al.

Turkish Journal of Medical Sciences , cilt.55, sa.4, ss.1039-1062, 2025 (SCI-Expanded, Scopus, TRDizin)

11. Candidemia in critically ill COVID-19 patients: Risk factors and impact on mortality

KAZANCIOĞLU S., BODUR H., MUMCUOĞLU İ., BAŞTUĞ A., Ozbay B. O., Aydos O., et al.

Heliyon , cilt.10, sa.6, 2024 (SCI-Expanded, Scopus)

12. Concordance and generalization of an AI algorithm with real-world clinical data in the pre-omicron and omicron era

YILMAZ G., Sezer S., BAŞTUĞ A., Singh V., Gopalan R., Aydos O., et al.

Heliyon , cilt.10, sa.3, 2024 (SCI-Expanded, Scopus)

13. Rare Conditions of Candidemia: Risk Factors and Outcomes for Mixed Candidemia and Late Recurrent Candidemia Nadir Kandidemi Durumları: Mikst Kandidemi ve Geç Tekrarlayan Kandidemi için Risk Faktörleri ve Sonuçları

Özbay B. O., BAŞTUĞ A., Aydos Ö., Kemirtlek N., GÖKÇINAR D., DİNÇ B., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.13, 2024 (ESCI, Scopus, TRDizin)

14. The usefulness of hematological parameters and cerebrospinal fluid indexes in the differential diagnosis of acute bacterial from viral meningitis

KAZANCIOĞLU S., BAŞTUĞ A., Ozbay B. O., Tezcan H., Buyuktarakci C., Akbay A., et al.

Diagnostic Microbiology and Infectious Disease , cilt.107, sa.1, 2023 (SCI-Expanded, Scopus)

15. An investigation of clinical characteristics and antimicrobial agent susceptibility patterns in clinical Comamonas testosteroni isolates: An increasingly prevalent nosocomial pathogen

Ozbay B. O., Aypak A., BAŞTUĞ A., Aydos Ö., MUMCUOĞLU İ., Büyükberber S. G., et al.

Infectious Diseases Now , cilt.53, sa.2, 2023 (SCI-Expanded, Scopus)

16. Neurological Presentations in Patients with COVID-19 in Cytokine Storm

Tutal Gursoy G., Yuksel H., Mulkem Simsek I., Oral S., Erdogan Kucukdagli F., Karaman A., et al.

Canadian Journal of Neurological Sciences , cilt.50, sa.1, ss.89-95, 2023 (SCI-Expanded, Scopus)

17. The Prevalence of Sexually Transmitted Infections and Related Factors Among People Living with HIV in Turkey Türkiye’de HIV ile Yaşayan Bireylerde Cinsel Yolla Bulaşan Enfeksiyonların Sıklığı ve Risk Faktörleri

Taşpinar Şen E., BAŞTUĞ A., Aypak A., BODUR H.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.12, 2023 (ESCI, Scopus, TRDizin)

18. Systematic Review of the Implementation of Artificial Intelligence in the Diagnosis of Central Nervous System Infections Santral Sinir Sistemi Enfeksiyonları Tanısında Yapay Zeka Uygulamaları ile İlgili Sistematik Derleme

BAŞTUĞ A., Özbay B. O., Öksüz E., Karabay O.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.12, 2023 (ESCI, Scopus, TRDizin)

19. Safety, Efficacy and Direct/Indirect Cost Analysis of an Outpatient Antimicrobial Therapy Unit: A Prospective Cohort Study from Turkey

Özbay B. O., BAŞTUĞ A., Öksüz E., BODUR H.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.12, 2023 (ESCI, Scopus, TRDizin)

20. Evaluation of the models generated from clinical features and deep learning-based segmentations: Can thoracic CT on admission help us to predict hospitalized COVID-19 patients who will require intensive care?

Gülbay M., BAŞTUĞ A., Özkan E., Öztürk B. Y., Mendi B. A. R., BODUR H.

BMC Medical Imaging , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

21. Prognostic Value of Hemogram-Derived Ratios in Patients with Crimean-Congo Hemorrhagic Fever

KAZANCIOĞLU S., BAŞTUĞ A., Ozdemir B., AKINCI E., BODUR H.

Vector-Borne and Zoonotic Diseases , cilt.22, sa.9, ss.465-471, 2022 (SCI-Expanded, Scopus)

22. Eggerthia catenaformis-related peritonitis in a patient with peritoneal dialysis

Özbay B. O., BAŞTUĞ A., Köksal Cevher Ş., Yenigün E. C., MUMCUOĞLU İ., BODUR H.

Anaerobe , cilt.75, 2022 (SCI-Expanded, Scopus)

23. The changing dynamics of neutralizing antibody response within 10 months of SARS-CoV-2 infections

BAŞTUĞ A., BODUR H., Aydos O., KORKULU N., Oksuz E., ÖZKUL A.

Journal of Medical Virology , cilt.94, sa.5, ss.1983-1989, 2022 (SCI-Expanded, Scopus)

24. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

MERT A., VAHABOĞLU H., Arslan F., BATIREL A., Saraçoğlu K. T., BAŞTUĞ A., et al.

Rheumatology International , cilt.42, sa.3, ss.457-467, 2022 (SCI-Expanded, Scopus)

25. PARA-INFECTIOUS GUILLAIN BARRE SYNDROME IN A PATIENT DIAGNOSED WITH COVID-19

BAŞTUĞ A., BEKTAŞ H., Buyuktarakci C., BODUR H.

Ankara Medical Journal , cilt.22, sa.1, ss.167-171, 2022 (Scopus, TRDizin)

26. Diagnostic value of β-D-glucan alone or combined with Candida score, colonization index and C-reactive protein for candidemia

KAZANCIOĞLU S., BAŞTUĞ A., KAYAASLAN B., MUTLU N. M., Calci E., TURHAN T., et al.

Journal of Infection in Developing Countries , cilt.16, sa.2, ss.362-368, 2022 (SCI-Expanded, Scopus)

27. Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A single-center cohort study

BAŞTUĞ S., Çavdarlı B., BAŞTUĞ A., ŞENCAN İ., Tunçez E., Çakır E. Y., et al.

Anatolian Journal of Cardiology , cilt.26, sa.2, ss.133-140, 2022 (SCI-Expanded, Scopus, TRDizin)

28. Neutralizing antibody response and associated factors in Coronavirus-19 disease (COVID-19) up to one month

BAŞTUĞ A., BODUR H., ŞEKER U. Ö. Ş., KORKULU N., Aydos O., Kehribar E. S., et al.

Turkish Journal of Biochemistry , cilt.47, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus, TRDizin)

29. Analysis of the National Antifungal Consumption Data of Turkey During 2013-2019 Türkiye’nin 2013-2019 Yılları Ulusal Antifungal Tüketim Verilerinin Analizi

BAŞTUĞ A., Aksoy M., Işli F., Karabay O.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.11, sa.1, 2022 (Scopus)

30. Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases

GÜNER H. R., KAYAASLAN B., HASANOĞLU İ., Aypak A., BODUR H., ATEŞ İ., et al.

BMC Infectious Diseases , cilt.21, sa.1, 2021 (SCI-Expanded, Scopus)

31. Predictive performance of CT for adverse outcomes among COVID-19 suspected patients: A two-center retrospective study

Baysal B., Dogan M. B., Gulbay M., Sorkun M., Koksal M., BAŞTUĞ A., et al.

Bosnian Journal of Basic Medical Sciences , cilt.21, sa.6, ss.738-744, 2021 (SCI-Expanded, Scopus)

32. SARS-CoV-2 Detection with de Novo-Designed Synthetic Riboregulators

Köksaldl İ. Ç., Köse S., Ahan R. E., Haclosmanoǧlu N., Şahin Kehribar E., Güngen M. A., et al.

Analytical Chemistry , cilt.93, sa.28, ss.9719-9727, 2021 (SCI-Expanded, Scopus)

33. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective

BAŞTUĞ A., Oksuz E., KAZANCIOĞLU S., Malhan S., Ozbay B. O., BODUR H.

International Journal of Clinical Practice , cilt.75, sa.6, 2021 (SCI-Expanded, Scopus)

34. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19

KAZANCIOĞLU S., Yilmaz F. M., BAŞTUĞ A., Sakalll A., Ozbay B. O., Buyuktarakci C., et al.

Viral Immunology , cilt.34, sa.5, ss.342-351, 2021 (SCI-Expanded, Scopus)

35. Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent

BAŞTUĞ A., Aslaner H., Aybar Bilir Y., Kemirtlek N., Gursoy F. M., BAŞTUĞ S., et al.

Rheumatology International , cilt.41, sa.5, ss.993-1008, 2021 (SCI-Expanded, Scopus)

36. A CT radiomics analysis of COVID-19-related ground-glass opacities and consolidation: Is it valuable in a differential diagnosis with other atypical pneumonias?

Gülbay M., Özbay B. O., Mendi B. A. R., BAŞTUĞ A., BODUR H.

PLoS ONE , cilt.16, sa.3 March, 2021 (SCI-Expanded, Scopus)

37. Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir

GÜNER H. R., HASANOĞLU İ., KAYAASLAN B., Aypak A., AKINCI E., BODUR H., et al.

Journal of Infection and Public Health , cilt.14, sa.3, ss.365-370, 2021 (SCI-Expanded, Scopus)

38. Assessment of galectin-1, galectin-3, and prostaglandin e2 levels in patients with covid-19

KAZANCIOĞLU S., Yilmaz F. M., BAŞTUĞ A., Ozbay B. O., Aydos O., Yücel Ç., et al.

Japanese Journal of Infectious Diseases , cilt.74, sa.6, ss.530-536, 2021 (SCI-Expanded, Scopus)

39. Molecular characterization of human adenoviruses associated with respiratory infection in Turkey

BAŞTUĞ A., Altas A. B., Koc B. T., Bayrakdar F., Korukluoglu G., BODUR H., et al.

APMIS , cilt.129, sa.1, ss.23-31, 2021 (SCI-Expanded, Scopus)

40. Platelet hyperreactivity related with covid- 19 disease severity

Tuncay M. E., BAŞTUĞ A., Erdogan S., KAZANCIOĞLU S., Yakisik E., ERDEM D., et al.

Ankara Medical Journal , cilt.23, sa.1, ss.386-397, 2021 (Scopus, TRDizin)

41. The role of haematological parameters in patients with COVID-19 and influenza virus infection

KAZANCIOĞLU S., BAŞTUĞ A., Ozbay B. O., Kemirtlek N., BODUR H.

Epidemiology and Infection , cilt.148, 2020 (SCI-Expanded, Scopus)

42. Clinical and laboratory features of COVID-19: Predictors of severe prognosis

BAŞTUĞ A., BODUR H., Erdogan S., GÖKÇINAR D., KAZANCIOĞLU S., Kosovali B. D., et al.

International Immunopharmacology , cilt.88, 2020 (SCI-Expanded, Scopus)

43. Virolactia in an Asymptomatic Mother with COVID-19

BAŞTUĞ A., Hanifehnezhad A., TAYMAN C., ÖZKUL A., Ozbay O., KAZANCIOĞLU S., et al.

Breastfeeding Medicine , cilt.15, sa.8, ss.488-491, 2020 (SCI-Expanded, Scopus)

44. Evaluation of epidemiological, clinical, and laboratory features and mortality of 144 HIV/AIDS cases in Turkey

Ozdemir B., Yetkin M. A., BAŞTUĞ A., But A., Aslaner H., AKINCI E., et al.

HIV Clinical Trials , cilt.19, sa.2, ss.69-74, 2018 (SCI-Expanded, Scopus)

45. Evaluation of surgical site infections detected in a tertiary care hospital Üçüncü basamak bir hastanede tespit edilen cerrahi alan enfeksiyonlarinin değerlendirilmesi

Aslaner H., AKINCI E., But A., Kanyilmaz D., BAŞTUĞ A., Aypak A., et al.

Turk Hijyen ve Deneysel Biyoloji Dergisi , cilt.75, sa.3, ss.265-276, 2018 (Scopus, TRDizin)

46. Antibiotic consumption, resistance data, and prevention strategies Antibiyotik Tüketimi, Direnç Verileri ve Önlem Stratejileri

Karabay O., BAŞTUĞ A., ÖZTÜRK R., ŞENCAN İ., Aksoy M., Şi̇Mşek H., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.2018, sa.7, ss.7-35, 2018 (Scopus)

47. Tetanus in adults: results of the multicenter ID-IRI study

TOSUN S., BATIREL A., Oluk A., AKSOY F., Puca E., Bénézit F., et al.

European Journal of Clinical Microbiology and Infectious Diseases , cilt.36, sa.8, ss.1455-1462, 2017 (SCI-Expanded, Scopus)

48. MicroRNA expression profiles in patients with acute Crimean Congo hemorrhagic fever reveal possible adjustments to cellular pathways

Demir Z. C., BAŞTUĞ A., BODUR H., Ergunay K., ÖZKUL A.

Journal of Medical Virology , cilt.89, sa.3, ss.417-422, 2017 (SCI-Expanded, Scopus)

49. Analysis of epidemiology and risk factors for mortality in ventilator-associated pneumonia attacks in intensive care unit patients

But A., Yetkin M. A., Kanyilmaz D., Aslaner H., BAŞTUĞ A., Aypak A., et al.

Turkish Journal of Medical Sciences , cilt.47, sa.3, ss.812-816, 2017 (SCI-Expanded, Scopus, TRDizin)

50. Quality of life and related factors among chronic hepatitis B-infected patients: A multi-center study, Turkey

KARACAER Z., ÇAKIR B., ERDEM H., Ugurlu K., Durmus G., Ince N. K., et al.

Health and Quality of Life Outcomes , cilt.14, sa.1, 2016 (SCI-Expanded, SSCI, Scopus)

51. Crimean-congo hemorrhagic fever: Prognostic factors and the association of leukocyte counts with mortality

BAŞTUĞ A., Kayaaslan B., KAZANCIOĞLU S., Aslaner H., But A., AKINCI E., et al.

Japanese Journal of Infectious Diseases , cilt.69, sa.1, ss.51-55, 2016 (SCI-Expanded, Scopus)

52. Necrotizing fasciitis due to Streptococcus mitis caused by accidental human bite

BAŞTUĞ A., Kislak S., MUTLU N. M., Akcaboy Z. N., Koksal A., SERTÇELİK A., et al.

Journal of Infection in Developing Countries , cilt.10, sa.1, ss.100-102, 2016 (SCI-Expanded, Scopus)

53. A long-term survey of brucellosis: Is there any marker to predict the complicated cases?

KAYAASLAN B., BAŞTUĞ A., Aydin E., AKINCI E., But A., Aslaner H., et al.

Infectious Diseases , cilt.48, sa.3, ss.215-221, 2016 (SCI-Expanded, Scopus)

54. Investigating the in vitro synergistic activities of several antibiotic combinations against carbapenem-resistant Acinetobacter baumannii isolates

Yavaş S., Yetkın M. A., Kayaaslan B., BAŞTUĞ A., Aslaner H., But A., et al.

Turkish Journal of Medical Sciences , cilt.46, sa.3, ss.892-896, 2016 (SCI-Expanded, Scopus, TRDizin)

55. Does the course of laboratory parameters help us to predict the outcome of CCHF?

KAZANCIOĞLU S., AKINCI E., BAŞTUĞ A., KAYAASLAN B., But A., Aslaner H., et al.

Turkish Journal of Medical Sciences , cilt.46, sa.2, ss.328-334, 2016 (SCI-Expanded, Scopus, TRDizin)

56. Emergence of multidrug resistant isolates and mortality predictors in patients with solid tumors or hematological malignancies

BAŞTUĞ A., Kayaaslan B., KAZANCIOĞLU S., But A., Aslaner H., AKINCI E., et al.

Journal of Infection in Developing Countries , cilt.9, sa.10, ss.1100-1107, 2015 (SCI-Expanded, Scopus)

57. The knowledge of the physicians about sepsis bundles is suboptimal: A multicenter survey

Tufan Z. K., ESER F., Vudali E., BATIREL A., Kayaaslan B., BAŞTUĞ A., et al.

Journal of Clinical and Diagnostic Research , cilt.9, sa.7, 2015 (Scopus)

58. Ebola viral disease: What should be done to combat the epidemic in 2014?

BAŞTUĞ A., BODUR H.

Turkish Journal of Medical Sciences , cilt.45, sa.1, 2015 (SCI-Expanded, Scopus, TRDizin)

59. A case of Crimean-Congo hemorrhagic fever complicated with acute pancreatitis

BAŞTUĞ A., Kayaaslan B., But A., Aslaner H., SERTÇELİK A., AKINCI E., et al.

Vector-Borne and Zoonotic Diseases , cilt.14, sa.11, ss.827-829, 2014 (SCI-Expanded, Scopus)

60. Analysis of 161 adult patients with brucellosis

Kayaaslan B., AKINCI E., BAŞTUĞ A., Eren S. S., ÖNGÜRÜ P., But A., et al.

Turkish Journal of Medical Sciences , cilt.43, sa.2, ss.187-193, 2013 (SCI-Expanded, Scopus, TRDizin)

61. Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens

Yilmaz G. R., BAŞTUĞ A., But A., Yildiz S., Yetkin M. A., Kanyilmaz D., et al.

Journal of Infection and Chemotherapy , cilt.19, sa.1, ss.57-62, 2013 (SCI-Expanded, Scopus)

62. Risk factors for mortality in patients with nosocomial Staphylococcus aureus bacteremia

BAŞTUĞ A., Yilmaz G. R., Kayaaslan B., AKINCI E., BODUR H.

Turkish Journal of Medical Sciences , cilt.42, sa.SUPPL.1, ss.1222-1229, 2012 (SCI-Expanded, Scopus, TRDizin)

63. Brucellosis mimicking enteric fever

ERBAY A., BODUR H., AKINCI E., BAŞTUĞ A., Çevik M. A.

Journal of Infection in Developing Countries , cilt.3, sa.3, ss.239-240, 2009 (Scopus)

64. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality

Çevik M. A., ERBAY A., BODUR H., Gülderen E., BAŞTUĞ A., Kubar A., et al.

International Journal of Infectious Diseases , cilt.12, sa.4, ss.374-379, 2008 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim